IOL Chemicals to invest in capacity expansion at Punjab facilityIllustrative image – not actual.

IOL Chemicals and Pharmaceuticals plans to invest around Rs 350 crore to expand its ibuprofen manufacturing capacity at its existing facility in Barnala, Punjab.

The company will establish a new fully backward-integrated unit, and once commissioned, the expansion will increase IOL Chemicals’ total ibuprofen manufacturing capacity to 18,000 MTPA from the current 12,000 MTPA. The project will be funded through internal accruals and is scheduled for commissioning by December 2027. IOL Chemicals said its existing ibuprofen facilities are operating at approx. 95 percent capacity, prompting the expansion to meet growing global demand and provide additional production capacity for international markets.

Separately, IOL Chemicals has commissioned a pharmaceutical formulation plant at its Barnala site, marking its entry into contract development and manufacturing (CDMO) services for pharmaceutical formulations.

← All latest storiesBack to top →